Baogui Wang

Dr. Baogui Wang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

8 April 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
JDJingyu Deng
Jingyu Deng
HLHan Liang
Han Liang
GYGuoguang Ying
Guoguang Ying
RZRupeng Zhang
Rupeng Zhang
BWBaogui Wang
Baogui Wang
XHXishan Hao
Xishan Hao
RNF 180, a novel tumor suppressor, has been implicated in the carcinogenesis and progress of gastric cancer. At present study, we found that lower expression of RNA180 was specific in gastric cancer tissues, and the inconsistently methylated levels of RNF180 promoter were identified in the gastric cancer tissues. Importantly, we demonstrated that the methylated CpG site count and four hypermethylated CpG sites (-116, -80, +97, and +102) were significantly associated with the survival of 400 gastric cancer patients, respectively. With multivariate survival analyses, we demonstrated that both the methylation of combined CpG (-116, -80, +97, and +102) sites and N stage were the independent indictor of prognosis of gastric cancer patients. Eventually, the methylation of combined CpG (-116, -80, +97, and +102) sites was identified to have smaller AIC value than N stage by mean of AIC calculation with the Cox proportional hazards model. These findings indicated that the quantitative detection of RNF180 promoter methylation had the intensive feasibility for evaluation the prognosis of gastric cancer patients in clinic.

25 February 2013 in Oncology Research and Treatment
Verified
Journal Article
Closed access
HZHongjie Zhan
Hongjie Zhan
HLHan Liang
Han Liang
XLXiangyu Liu
Xiangyu Liu
JDJingyu Deng
Jingyu Deng
BWBaogui Wang
Baogui Wang
XHXishan Hao
Xishan Hao
Background: The aim of this study was to investigate the relationship between the expression of hypoxia-inducible factor-1α (HIF-1α), Ras-related C3 botulinum toxin substrate 1 (Rac1), and vascular endothelial growth factor (VEGF), as well as their correlation with angiogenesis and prognosis in gastric carcinoma. Material and Methods: The expression of Rac1, HIF-1α, VEGF, and CD34 (described in terms of microvessel density, MVD) was determined by immunohistochemical staining of tissues from 60 radically resected gastric cancer specimens. Results: The proportion of specimens expressing Rac1, HIF-1α, and VEGF was 37/60 (61.7%), 35/60 (58.3%), and 40/60 (66.7%), respectively. The levels of Rac1, HIF-1α, and VEGF expression were significantly correlated with Lauren's classification, lymph node metastasis, and pathologic staging (p < 0.05). There were positive correlations between MVD and the expression of Rac1, HIF-1α, and VEGF. The mean survival time and 5-year survival rate in cases with positive Rac1, HIF-1α, and VEGF expression and MVD ≥ 26.3 were significantly shorter than those with negative Rac1, HIF-1α, and VEGF expression and MVD < 26.3. Conclusion: Rac1, HIF-1α, and VEGF play an important role in tumor invasion and metastasis, especially in tumor angiogenesis. Thus, testing the expression of Rac1, HIF-1α, and VEGF may be a useful index for treatment and prognosis.

1 January 2024 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
HXHaibo Xu
Haibo Xu
BWBaogui Wang
Baogui Wang
In recent years, based on the frequent occurrence of medical disputes, the doctor–patient relationship has gradually become tense1, which not only seriously affects the medical industry but also becomes one of the social disharmony factors. A good doctor–patient relationship is a prerequisite for improving the compliance, satisfaction, and loyalty of patients and their families, and at the same time, doctors can reasonably take the best treatment measures to achieve satisfactory treatment results2. It shows that doctors have the key to establish a harmonious doctor–patient relationship.

10 June 2025 in Molecular Medicine Reports
Verified
Journal Article
Closed access
PDF file
HXHaibo Xu
Haibo Xu
BWBaogui Wang
Baogui Wang
QWQi Wang
Qi Wang
CSChunlong Sun
Chunlong Sun
WDWen Du
Wen Du
With the improvement in the material standard of living of individuals and a decrease in physical activity, which has led to a significant increase in the incidence of obesity and its related metabolic diseases, non‑alcoholic fatty liver disease (NAFLD) is increasingly becoming one of the more common metabolic disorders of the liver that threatens public health. Lipid deposits in the liver cause simple hepatic steatosis to develop into non‑alcoholic steatohepatitis (NASH), which causes severe damage to the organism; however, the key mechanisms responsible for the progression of NASH remain unclear. Therefore, the active and effective correction of the imbalance of energy metabolism in the organism is a common health challenge for humans. The present review summarized the research progress made on fatty acid biology, namely medium‑chain fatty acids (MCFAs) and the causes of the pathogenesis of NAFLD, the induction of apoptosis, oxidative stress, immune regulation and related lipid metabolism signaling pathways. The present review provided evidence supporting MCFAs as a potential therapeutic intervention for NAFLD by regulating lipid metabolism and reducing oxidative stress.

1 January 2024 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
BWBaogui Wang
Baogui Wang
HXHaibo Xu
Haibo Xu